Case Note & Summary
The case involved appeals by T.N. Dadha Pharmaceuticals against the Collector of Central Excise regarding the withdrawal of exemption for Darzamol Injection I.V. under Notification No. 116/69. The assessee claimed that the drug contained Metronidazole and Dextrose, with the latter being a non-therapeutic ingredient. Initially, the exemption was granted, but a show-cause notice was issued alleging suppression of facts regarding Dextrose. The Assistant Collector dropped the proceedings, but the Principal Collector later initiated new proceedings, leading to the withdrawal of the exemption. The assessee appealed to the Customs, Excise and Gold (Control) Appellate Tribunal (CEGAT), which upheld the Collector's decision. The Supreme Court examined whether the withdrawal of exemption was justified and if the extended period for duty demand under Section 11-A(1) was applicable. The court found that the Revenue did not prove suppression of facts, as the classification list did not show Dextrose was omitted. Consequently, the court ruled that the withdrawal of exemption was unjustified and set aside the demand for the extended period, allowing the appeals and stating that authorities could raise a fresh demand within the limitation period. No costs were awarded.
Headnote
A) Central Excise - Exemption Withdrawal - Justification of Withdrawal - Central Excise Act, 1944, Section 11-A - The court found that the withdrawal of exemption for Darzamol Injection was unjustified as the Revenue failed to prove suppression of facts regarding Dextrose in the classification list. The court held that the burden of proof lay with the Revenue, which was not discharged, leading to the conclusion that the exemption should not have been withdrawn (Paras 1-5). B) Central Excise - Extended Duty Demand - Applicability of Proviso to Section 11-A(1) - Central Excise Act, 1944, Section 11-A - The court ruled that the conditions for invoking the extended period for duty demand were not met, as there was no evidence of suppression of facts. The demand for excise duty for the extended period was set aside, allowing the appeals (Paras 6-10).
Issue of Consideration
Whether the withdrawal of exemption under Notification No. 116/69 was justified and whether the extended period for duty demand under Section 11-A(1) was applicable.
Final Decision
The Supreme Court allowed the appeals, set aside the withdrawal of exemption, and the demand for excise duty for the extended period was also set aside. The authorities were permitted to raise a fresh demand within the limitation period under Section 11-A of the Central Excise Act.
Law Points
- Central Excise Act
- 1944
- Section 11-A
- Notification No. 116/69
- excise duty exemption
- pharmaceutical necessity
- suppression of facts
